Valion Bio, Inc. (VBIO) stock
VBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.53+0.02 (+4.05%)
Close on Nov 13, 2026Market cap $2.20MP/E –Yield –
Valion Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Valion Bio's enterprise value was -$20.42K on Nov 11, 2026, against $72.01M a year earlier. Over the last 5 years it ranged from -$20.42K to $535.73M, with a median of $49.22M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$20.42K | -100.0% |
| 2025 | Dec 31, 2025 | $56.83M | +9.6% |
| 2024 | Dec 31, 2024 | $51.85M | -14.7% |
| 2023 | Dec 29, 2023 | $60.81M | -59.1% |
| 2022 | Dec 30, 2022 | $148.51M | – |
See a number that looks wrong?